MLYS
Mineralys Therapeutics, Inc.
28.30$
+1.0%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | – | – | – | – | +37.2% | |
| – | – | – | – | – | – | |
| – | +576.4% | +61.0% | +168.0% | +139.6% | -21.7% | |
| – | +354.3% | +116.3% | +173.4% | +66.6% | +62.0% | |
| – | +536.3% | +68.1% | +168.9% | +127.3% | -11.3% | |
| – | – | – | – | – | – | |
| – | -76.5% | +6,107.4% | – | – | – | |
| – | – | – | – | – | – | |
| – | -76.5% | -7,153.6% | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.